ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2057

Medical Trauma and Its Association with Pain and Disability Risk in Children with Inflammatory Arthritis

Leah Medrano1, Brenda Bursch1, Jennifer Weiss2, Alice Hoftman1, Joshua Li3, Nicholas Jackson3 and Deborah McCurdy1, 1David Geffen School of Medicine, UCLA, Los Angeles, CA, 2Hackensack Meridian School of Medicine, Hackensack, NJ, 3Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, CA

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, mental health, pain, Pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2039–2060) Pediatric Rheumatology – Clinical Poster III: Potpourri

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: This study aims to determine the prevalence of medical trauma and its impacts on outcomes in a sample of children with inflammatory arthritis. We hypothesize that medical trauma is an underrecognized entity in this population, and that it is associated with worse pain outcomes and disability risk.

Methods: Children aged 8-18 years with juvenile idiopathic arthritis (JIA) or juvenile lupus erythematosus (jSLE) with a history of inflammatory arthritis were recruited from a single center pediatric rheumatology clinic. Participants completed a questionnaire assessing for medical trauma related to their arthritis with an adapted Child PTSD Symptom Scale for DSM-V (CPSS-V). Further questionnaires assessed for self-efficacy to function despite pain (Child Self-Efficacy Scale), pain scores (Verbal Rating Scale, 0-10), juvenile fibromyalgia (JFM) (Pain and Symptom Assessment Tool), anxiety sensitivity (Childhood Anxiety Sensitivity Index), and other adverse childhood experiences (ACEs). Demographic and disease activity data were collected. Differences between those with and without probable medical PTSD (CPSS-V score >31 vs ≤ 31) were assessed using rank sum and exact tests. Linear regression examined continuous associations with CPSS-V.

Results: Fifty children and adolescents with JIA (n=42) or jSLE (n=8) completed the study. Twenty (40%) children had CPSS-V scores of moderate or greater severity and 7 (14%) scored in the probable medical PTSD range. Those with juvenile spondyloarthropathy and rheumatoid factor positive polyarticular JIA had the highest trauma scores, but there was no overall difference in trauma scores between JIA and jSLE. CPSS-V scores in the probable medical PTSD range were significantly associated with older age, higher pain and anxiety sensitivity scores, more ACEs and depression history, and higher JIA disease activity scores (cJADAS-10) but not jSLE activity scores (SLEDAI-2K). There was a trend towards poorer self-efficacy scores and meeting JFM criteria in the probable medical PTSD group. Poorer self-efficacy scores were significantly associated with higher CPSS-V scores when assessed as a continuous variable. Nine (18%) participants met criteria for JFM and had higher average trauma scores compared to those who did not. Trauma scores were not associated with history of hospitalization or injected medication use.

Conclusion: Medical trauma symptoms were reported by many participants in this cohort of children with inflammatory arthritis. Those who have experienced more trauma from their rheumatologic disease may be at risk for worse pain outcomes and increased disability, specifically poor self-efficacy and high anxiety sensitivity. Further studies are necessary to determine the true prevalence of medical trauma in this population, its impact on pain and disability, potential interventions, and the importance of trauma-informed care.

Supporting image 1

Table 1. Demographic and disease history data for children and adolescents with inflammatory arthritis, stratified by CPSS-V scores above or below the probable medical PTSD range (> 31). cJADAS_10 = Clinical Juvenile Arthritis Disease Activity Scores, 10 joints; CPSS-V = Child PTSD Symptom Scale for DSM-V; IV = intravenous; SLEDAI_2K = Systemic Lupus Erythematosus Disease Activity Index 2000; subQ = subcutaneous.

Supporting image 2

Table 2. Questionnaire score data for children and adolescents with inflammatory arthritis, stratified by CPSS-V scores above or below the probable medical PTSD range (> 31). Data represent median scores, unless otherwise stated. ACEs = Adverse Childhood Experiences questionnaire; CASI = Childhood Anxiety Sensitivity Index; CPSS-V = Child PTSD Symptom Scale for DSM-V; CSES = Child Self-Efficacy Scale; PSAT = Pain and Symptom Assessment Tool.


Disclosures: L. Medrano: None; B. Bursch: None; J. Weiss: None; A. Hoftman: None; J. Li: None; N. Jackson: None; D. McCurdy: None.

To cite this abstract in AMA style:

Medrano L, Bursch B, Weiss J, Hoftman A, Li J, Jackson N, McCurdy D. Medical Trauma and Its Association with Pain and Disability Risk in Children with Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/medical-trauma-and-its-association-with-pain-and-disability-risk-in-children-with-inflammatory-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/medical-trauma-and-its-association-with-pain-and-disability-risk-in-children-with-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology